Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-05

Clinical Trial Update: Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation [NA]

View source ↗

Summary

A prospective, non-randomized safety and efficacy study of a new left atrial appendage occluder design for minimally invasive closure in patients with atrial fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Left atrial appendage occluder (Occlutech) (left atrial appendage occluder)

Snippet

Sponsor: Occlutech International AB | Conditions: Atrial Fibrillation | NA | Status: COMPLETED